ScholarLens Back to search
2020•Biomedical Journal of Scientific & Technical ResearchOpen access

The Eradication Rate of Levofloxacin containing Quadruple therapy for the First-Line treatment of Helicobacter Pylori

Tran Thi Khanh Tuong

Open full text 1 citations

Abstract

containing Quadruple therapy for the First-Line treatment of Helicobacter Pylori.

Open-access reader

About this research paper

What this paper is about

containing Quadruple therapy for the First-Line treatment of Helicobacter Pylori.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

containing Quadruple therapy for the First-Line treatment of Helicobacter Pylori.

Key concepts: Ho chi minh, Levofloxacin, Medicine, Helicobacter pylori, Traditional medicine, Family medicine, Internal medicine, Geography

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Eradication Rate of Levofloxacin containing Quadruple therapy for the First-Line treatment of Helicobacter Pylori — Research Paper | ScholarLens